Basking in praise and a $4.2B GSK pact, Merck KGaA blueprints expansion plans for Boston-area R&D campus
Fresh on the heels of announcing a multibillion-dollar development pact with GlaxoSmithKline, Merck KGaA is showing off its blueprint for a big expansion of its R&D operations in Billerica, outside of Boston.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.